adenosine diphosphate has been researched along with moxalactam in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (87.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Freimer, EH; Ingalls, CS | 1 |
Metzler, CM; Peters, GR | 1 |
Hara, H; Inoue, T; Kakushi, H; Maruyama, T; Mihara, S; Okabayashi, T; Shike, T; Shirai, D; Takeda, Y; Uchida, K | 1 |
Matsubara, T; Mizuno, A; Nakashima, M; Takiguchi, Y; Uchida, K; Uematsu, T | 1 |
Kakushi, H; Shike, T; Uchida, K | 1 |
Ishigami, T; Komeno, T; Konishi, M; Nakamura, M; Uchida, K | 1 |
Baird, A; Chamberlain, PD; Nunn, B | 1 |
Aber, RC; Weitekamp, MR | 1 |
2 trial(s) available for adenosine diphosphate and moxalactam
Article | Year |
---|---|
The effects of cefmetazole and latamoxef on platelet function in healthy human volunteers.
Topics: Adenosine Diphosphate; Adult; Bleeding Time; Blood Platelets; Cefmetazole; Female; Humans; Male; Middle Aged; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Prothrombin Time | 1989 |
Effect of temocillin and moxalactam on platelet responsiveness and bleeding time in normal volunteers.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Bleeding Time; Blood Platelets; Collagen; Humans; Male; Moxalactam; Penicillins; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic | 1985 |
6 other study(ies) available for adenosine diphosphate and moxalactam
Article | Year |
---|---|
Detection of antibiotic-induced platelet dysfunction in whole blood using flow cytometry.
Topics: Adenosine Diphosphate; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Blood Platelet Disorders; Cefotetan; Cefoxitin; Epinephrine; Flow Cytometry; Fluorescein; Fluoresceins; Goats; Humans; Immunoglobulin G; Mice; Moxalactam; P-Selectin; Platelet Activation; Platelet Membrane Glycoproteins; Tetrazoles | 1992 |
Effects of latamoxef on in vitro and ex vivo thromboxane A2 generation in human platelets.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cell Membrane; Humans; Moxalactam; Platelet Aggregation; Thromboxane A2 | 1988 |
Phase I clinical studies of 7432-S: effect of 7432-S on platelet aggregation and blood coagulation.
Topics: Adenosine Diphosphate; Adult; Animals; Anti-Bacterial Agents; Blood Coagulation; Cefaclor; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalexin; Cephalosporins; Collagen; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Male; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Effect of latamoxef (moxalactam) and its related compounds on platelet aggregation in vitro--structure activity relationships.
Topics: Adenosine Diphosphate; Carbenicillin; Cefotaxime; Ceftizoxime; Collagen; Humans; In Vitro Techniques; Male; Moxalactam; Platelet Aggregation; Structure-Activity Relationship | 1987 |
Effect of latamoxef on platelet function and prothrombin time in partially nephrectomized rats.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Creatinine; Glomerular Filtration Rate; Male; Moxalactam; Nephrectomy; Prothrombin Time; Rats; Rats, Inbred Strains; Tetrazoles; Vitamin K Deficiency | 1987 |
Prolonged bleeding times and bleeding diathesis associated with moxalactam administration.
Topics: Adenosine Diphosphate; Aged; Bacterial Infections; Bleeding Time; Blood Platelets; Cephalosporins; Cephamycins; Female; Hemorrhagic Disorders; Humans; Male; Middle Aged; Moxalactam; Platelet Aggregation; Platelet Function Tests | 1983 |